NCT04498156

Brief Summary

In this survey study, researchers want to find out more about how physicians are treating patients diagnosed with reduced kidney function (chronic kidney disease, CKD) and high blood sugar level (type 2 diabetes); what physicians know about the different treatment options available; and how they use this knowledge to treat their patients successfully. Additionally, researchers want to gather information about patient's awareness of their disease and which criteria they consider important for their treatment of the disease. The study will survey a total of 150 patients with type 2 diabetes: 50 patients with mild CKD; 50 patients with moderate CKD; and 50 patients with severe CKD. Patients eligible for this study can be male or female and should be at least 18 years old. In addition, a total of 150 physicians will be surveyed. Physicians eligible for this study may be general practitioners, endocrinologist, or nephrologists.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 4, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

September 16, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

April 21, 2022

Status Verified

April 1, 2022

Enrollment Period

8 months

First QC Date

July 31, 2020

Last Update Submit

April 20, 2022

Conditions

Renal Insufficiency, Chronic

Keywords

Chronic kidney disease (CKD)Type 2 Diabetes (T2D)Patient awarenessPhysician awarenessInteraction patient physician

Outcome Measures

Primary Outcomes (3)

  • Awareness of chronic kidney disease in T2D

    Awareness will be summarized descriptively based on various survey questions.

    1 day

  • Values regarding chronic kidney disease in T2D

    Values regarding risks, consequences and management of chronic kidney disease will be summarized descriptively based on various survey questions.

    1 day

  • Preferences regarding chronic kidney disease in T2D

    Preferences regarding risks, consequences and management of chronic kidney disease will be summarized descriptively based on various survey questions.

    1 day

Secondary Outcomes (3)

  • Awareness of available treatments for chronic kidney disease in T2D

    1 day

  • Physician awareness of available referral tools for the management of chronic kidney disease in T2D

    1 day

  • Time point of communicated CKD diagnosis

    1 day

Study Arms (2)

CKD-Patients

Cohort consisting of adult patients with a known diagnosis of type 2 diabetes and evidence of chronic kidney disease (CKD)

Other: No intervention

Physicians treating CKD

Cohort consisting of licensed general practitioners, endocrinologists and nephrologists who are currently treating patients with both chronic kidney disease (CKD) and type 2 diabetes

Other: No intervention

Interventions

No interventionOTHER

No intervention, observational study

CKD-PatientsPhysicians treating CKD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with CKD and T2DM and treating general practitioners, endocrinologists, nephrologists in Canada

You may qualify if:

  • For patient cohort:
  • Diagnosis of type 2 diabetes
  • eGFR \< 60 ml/min per 1.73 m2 (measured within the last year) OR eGFR ≥ 60 ml/min per 1.73 m2 and uACR ≥ 2 (measured within the last year)
  • No documented non-diabetic etiology for renal disease
  • For physician cohort:
  • Licensed general practitioner, endocrinologist or nephrologist
  • Currently providing care for patients with chronic kidney disease and type 2 diabetes

You may not qualify if:

  • Patients with chronic kidney disease and type 2 diabetes who are physicians
  • Physicians with chronic kidney disease and type 2 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Many Facilities

Multiple Locations, Canada

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2020

First Posted

August 4, 2020

Study Start

September 16, 2020

Primary Completion

April 30, 2021

Study Completion

April 30, 2021

Last Updated

April 21, 2022

Record last verified: 2022-04

Locations

CA(1)